summary
Introduced
02/13/2026
02/13/2026
In Committee
02/13/2026
02/13/2026
Crossed Over
Passed
Dead
Introduced Session
2026 Regular Session
Bill Summary
Requiring certain centers where mammography testing is performed to include in the screening results letter that is sent to a patient, as required by federal law, a notice of the presence of arterial calcification as observed during the patient's mammogram.
AI Summary
This bill requires that any facility performing mammography testing, referred to as a "center," must include a specific notice in the mammogram results letter sent to patients, as mandated by federal law. This notice will inform patients if arterial calcification, which is the hardening of arteries in the breast, is observed during their mammogram. The bill clarifies that while arterial calcification is a common finding, it can be an indicator of increased risk for cardiovascular disease, and patients with this finding are advised to discuss it with their physician to assess their cardiovascular risks and determine if further testing is needed. This provision is intended to raise patient awareness and facilitate conversations with their doctors about potential cardiovascular risks, in addition to informing them about breast density findings, which are also included in the notice. The bill also specifies that this requirement takes effect on October 1, 2026.
Committee Categories
Health and Social Services
Sponsors (1)
Last Action
House Health Hearing (13:00:00 2/24/2026 ) (on 02/24/2026)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/HB1364?ys=2026RS |
| BillText | https://mgaleg.maryland.gov/2026RS/bills/hb/hb1364f.pdf |
Loading...